Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-line Non-small-cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05722015
What this trial is testing

Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 377
Testing effectiveness (Phase 2)Study completedNCT02879617
What this trial is testing

A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients

Who this might be right for
Non-Small Cell Lung Cancer NSCLC
Academic Thoracic Oncology Medical Investigators Consortium 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT04884282
What this trial is testing

Efficacy of Tedopi Plus Docetaxel or Tedopi Plus Nivolumab as Second-line Therapy in Metastatic Non-small-cell Lung Cancer Progressing After First-line Chemo-immunotherapy (Combi-TED)

Who this might be right for
Metastatic Non Small Cell Lung Cancer
Fondazione Ricerca Traslazionale 105
Testing effectiveness (Phase 2)Ended earlyNCT00313768
What this trial is testing

Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Pfizer 23
Testing effectiveness (Phase 2)Looking for participantsNCT06738160
What this trial is testing

The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer

Who this might be right for
NSCLCStereotactic Body Radiation Therapy (SBRT)Immunotherapy
Fudan University 27
Testing effectiveness (Phase 2)Study completedNCT02705820
What this trial is testing

Switch Maintenance Pembrolizumab in Patients With NSCLC After First Line Platinum Doublet Chemotherapy

Who this might be right for
Metastatic Non Small Cell Lung Cancer
Bank of Cyprus Oncology Centre 48
Large-scale testing (Phase 3)Study completedNCT03856411
What this trial is testing

Evaluate the Efficacy and Safety of Toripalimab or Placebo Combined With Chemotherapy in Treatment-naive Advanced NSCLC

Who this might be right for
Treatment-naive Advanced Non-small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd. 465
Large-scale testing (Phase 3)Study completedNCT03663205
What this trial is testing

A Study Evaluating the Efficacy and Safety of Tislelizumab Versus Chemotherapy in Advanced Non-Squamous Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
BeiGene 334
Testing effectiveness (Phase 2)Ended earlyNCT00766246
What this trial is testing

Phase II Avastin Trial for Stage IIIB/IV NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV
Pharmatech 125
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07549061
What this trial is testing

Vebreltinib Plus Chemotherapy as First-line Treatment for MET-overexpressing NSCLC

Who this might be right for
Lung Neoplasms
Shanghai Chest Hospital 19
Testing effectiveness (Phase 2)Ended earlyNCT06173505
What this trial is testing

Study of Vudalimab or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced NSCLC

Who this might be right for
Nonsquamous Non-small Cell Lung Cancer
Xencor, Inc. 28
Large-scale testing (Phase 3)Ended earlyNCT01319669
What this trial is testing

Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Chinese Society of Lung Cancer 11
Testing effectiveness (Phase 2)Study completedNCT01003964
What this trial is testing

Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV

Who this might be right for
Non Small Cell Lung Cancer
National Cancer Center, Korea 289
Testing effectiveness (Phase 2)Ended earlyNCT01057212
What this trial is testing

Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Providence Health & Services 6
Large-scale testing (Phase 3)Study completedNCT00148798
What this trial is testing

Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
Merck KGaA, Darmstadt, Germany 1,861
Testing effectiveness (Phase 2)UnknownNCT01097317
What this trial is testing

First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityFatigueLung Cancer+1 more
Wales Cancer Trials Unit 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT06020066
What this trial is testing

SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI

Who this might be right for
Brain MetastasesNon-small Cell Lung Cancer
Fudan University 202
Large-scale testing (Phase 3)Active Not RecruitingNCT05690945
What this trial is testing

QL1706 in Combination With Chemotherapy in PD-L1-Negative Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Qilu Pharmaceutical Co., Ltd. 606
Large-scale testing (Phase 3)Study completedNCT00130728
What this trial is testing

Evaluate the Efficacy of Bevacizumab in Combination With Tarceva for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Genentech, Inc. 636
Testing effectiveness (Phase 2)Study completedNCT00268970
What this trial is testing

Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Agennix 40
Next Page